Get Our Free Research Email
Conference Calendar 
May 20-23 - Current Concepts in Joint Replacement Spring 2012
May 23-25 - 13th EFORT Congress 2012
Complete Calendar »
|
Orthopedic and Dental Industry News
June 2011
Patterson announces F4Q sales . . . Medisafe pursuing an acquisition in the dental implant industry . . . Biolase announces $9 million private placement . . . Affineti Biologics receives research funding . . . MIS Implants Technologies launches PeriZone segment . . . Panasonic releases new intraoral camera . . . Securities fraud case against Align dismissed . . . 3M ESPE and BIOMET 3i to partner on intraoral impressions system for custom abutments more
Stryker completes Orthovita tender offer . . . ConforMIS to raise $68M . . . FDA clears Corin's highly cross-linked polyethylene liners and large diameter CoCr and BIOLOX Delta Ceramic heads . . . Aesculap launches Hydrolift Vertebral Body Replacement System . . . Cayenne Medical debuts the CrossFix II Meniscal Repair System . . . Mesoblast receives FDA clearance to begin phase II DDD study more
The backlash against Infuse is escalating this week with the announcement that the Spine Journal would dedicate its June issue to bias in published data on Infuse. In addition to highlighting the under-reporting of adverse events, the journal argues for improvements in transparency and disclosure requirements in the scientific literature. more
Researchers at the University of Gothenburg study the conductive effects of varying degrees of roughness on titanium dental implants and the result on patient healing time. more
Bonovo Orthopedics is launching Bonovo Recon, a new division dedicated solely to hip and knee products. Operations will begin this year with a suite of hip and knee implants available to Chinese markets. more
SNN acquires Tenet Medical Engineering . . . NUVA prices $350M offering . . . MedShape Solutions announces expanded 510(k) clearance for its ExoShape CL . . . X-spine receives CE market certification for AXLE Interspinous Fusion System . . . lluminOss Medical announces first case with a fractured ulna . . . Tornier launches Aequalis Ascend Convertible Shoulder System . . . Court rules in favor of Smith & Nephew in Arthrex patent case more
Dentsply has signed a definitive agreement to acquire Astra Tech at a valuation of $1.8 billion, approximately 3.4x 2010 sales. They will finance the transaction with cash on hand, commercial paper and long-term debt and expect the deal to close before the end of 2011. more
In a letter to Medtronic, Senators Baucus and Grassley requested documentation relating to Infuse consultants, adverse events, FDA reporting and journal articles. The investigation follows recent news concerning a link between Infuse and male sterility. more
The Financial Times broke rumors yesterday evening that Dentsply was the sole party negotiating to acquire Astra Tech. The deal is reportedly valued at about $1.8 billion. more
A new device developed at the University of Pittsburgh uses RFID technology to wirelessly transmit data about an orthopedic implant to physicians. The device, called Ortho-Tag, is attached to an implantable device, and information can be recalled later by holding a handheld probe to the patient's skin. more
Orthofix announced this morning that President and CEO Alan Milinazzo will resign as of August 1, though he will remain on the Board of Directors. Succeeding him will be Robert S. Vaters, the company's COO. more
Altor to acquire Orchid Orthopedic Solutions . . .Spinal Modulation closes $30M in funding . . . FDA approves DePuy's ceramic-on-metal hip . . . TSON announces 10,000th U.S. AxiaLIF implantation . . . Cayenne Medical partners with allograft supplier Parametrics more
The FDA posted minutes from a recent MDUFA reauthorization meeting, providing some insight into difficulties in the current user-fee program and goals for MDUFA III. The program is currently set to expire at the end of FY 2012. more
DePuy Orthopaedics announced today that Andrew Ekdahl has been promoted to the position of president, filling the role left vacant by the resignation of David Floyd in March. Mr. Ekdahl previously served as franchise vice president of DePuy Europe, Middle East and Africa. more
Synthes and Eli Lilly announced an “exclusive worldwide collaboration agreement” to jointly license, research and develop new and existing osteoporosis treatments. The agreement includes two development programs: Synthes' co-development of existing early stage compounds at Lilly, and the co-promotion of Lilly's current osteoperosis drug Foreto. more
BioMimetic Therapeutics announced on Tuesday that they've completed enrollment in their Augment Rotator Cuff Graft pilot study, and they've also been granted some additional patent protection for Augment through 2029. Despite this news, the stock sank to a new 52-week low. more
Brainlab to acquire Voyant Health . . . FDA clears ARTC's Spartan 6.5 Needled Anchor . . . Mazor Robotics launches next-gen Renaissance system . . . DFINE comments on VCF study results . . . Senators request investigation of PODs . . . Arteriocyte announces army stem-cell research project more
The orthopedics M&A spree continues with Stryker's acquisition of French extremity manufacturer Memometal Technologies. Stryker will pay $150 million in cash for the company, plus up to $12 million in milestone payments. Memometal recorded about $30 million in sales last year. more
DJO Global appointed Michael P. Mogul as the company’s new Chief Executive Officer, effective June 13, 2011. Mr. Mogul most recently served as Stryker’s Group President, Orthopaedics, and will be replaced by Kevin Lobo, current Group President, Neurotechnology and Spine. Mr. Mogul is replacing Les Cross at DJO, who announced his retirement in January. more
BioPoly receives CE mark for knee resurfacing system . . . ConforMIS receives CE mark for the iTotal CR . . . FDA clears Nimbic Systems' Air Barrier System . . Exactech launches the Proliant Polyaxial Pedicle Screw system . . . Zimmer showcases new products at EFORT more
ReGen hinted in March that they were considering their legal options following the FDA's decision to rescind Menaflex's market clearance, and now they've officially filed suit in D.C. court. more
Complete Archive
|
